eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2020
vol. 22
 
Share:
Share:
Review paper

A review and update on the use of Hibiscus sabdariffa (karkadeh) in the treatment of essential hypertension

Taqi Hashmi
1
,
Miaaz Zidan
1
,
Hanan Khudadad
1
,
Yahyaa Hashmi
2

1.
Primary Health Care Corporation, Qatar
2.
RCSI, Bahrain
Family Medicine & Primary Care Review 2020; 22(3): 240–243
Online publish date: 2020/10/16
Get citation
 
PlumX metrics:
 
1. Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation 2016; 134(6): 441–450, doi: 10.1161/CIRCULATIONAHA.115.018912.
2. Tailakh A, Evangelista LS, Mentes JC, et al. Hypertension prevalence, awareness, and control in Arab countries: a systematic review. Nurs Health Sci 2014; 16(1): 126–130, doi: 10.1111/nhs.12060.
3. Lacruz ME, Kluttig A, Hartwig S, et al. Prevalence and incidence of hypertension in the general adult population: results of the CARLA-Cohort Study. Medicine 2015; 94(22): e952, doi: 10.1097/MD.0000000000000952.
4. Guerrero-García C, Rubio-Guerra AF. Combination therapy in the treatment of hypertension. Drugs Context 2018; 7: 212531, doi: 10.7573/dic.212531.
5. Vrijens B, Vincze G, Kristanto P, et al. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336(7653): 1114–1117, doi: 10.1136/bmj.39553.670231.25.
6. Paczkowska A, Kopciuch D, Nowakowska E, et al. Compliance among adolescents with arterial hypertension. Adv Clin Exp Med 2016; 25(3): 441–448, doi: 10.17219/acem/33838.
7. Gupta P, Patel P, Štrauch B, et al. Risk factors for nonadherence to antihypertensive treatment Hypertension 2017; 69(6): 1113–1120, doi: 10.1161/hypertensionaha.116.08729.
8. Alhaddad IA, Hamoui O, Hammoudeh A, et al. Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence. Vasc Health Risk Manag 2016; 12: 407–413, doi: 10.2147/VHRM.S105921.
9. Abdelhalim HN, Zahrani AI, Shuaibi AM. Factors affecting treatment compliance of patients on antihypertensive therapy at National Guard Health Affairs (NGHA) Dammam Primary Health Care Clinics (PHCC). J Family Community Med 2019; 26(3): 168–172, doi: 10.4103/jfcm.JFCM_43_19.
10. Rahmawati R, Bajorek BV. Self-medication among people living with hypertension: a review. Fam Pract 2017; 34(2): 147–153, doi: 10.1093/fampra/cmw137.
11. Aykan DA, Aykan AC. Factors associated with the concomitant use of cardiovascular drugs and dietary herbal products: a cross-sectional study. J Cardiovasc Pharmacol Ther 2018, doi: 10.1177/1074248418794938.
12. Chrysant SG, Chrysant GS. Herbs used for the treatment of hypertension and their mechanism of action. Curr Hypertens Rep 2017; 19(9): 77, doi: 10.1007/s11906-017-0775-5.
13. Chrysant SG. The clinical significance and costs of herbs and food supplements used by complementary and alternative medicine for the treatment of cardiovascular diseases and hypertension. J Hum Hypertens 2016; 30(1): 1–6, doi: 10.1038/jhh.2015.42.
14. Fries CJ. Classification of complementary and alternative medical practices: Family physicians’ ratings of effectiveness. Can Fam Physician 2008; 54(11): 1570–1571.
15. Lei X, Chen J, Ren J, et al. Liver damage associated with Polygonum multiflorum Thunb.: a systematic review of case reports and case series. Evid Based Complement Alternat Med 2015; 2015: 459749, doi: 10.1155/2015/459749.
16. World Health Organization. WHO traditional medicine strategy: 2014–2023. 2015 Nov 20 [cited 2.09.2019]. Available from URL: http://www.who.int/medicines/publications/traditional/trm_strategy14_23/en/.
17. Da-Costa-Rocha I, Bonnlaender B, Sievers H, et al. Hibiscus sabdariffa L. – a phytochemical and pharmacological review. Food Chemistry 2014; 165: 424–443, doi: 10.1016/j.foodchem.2014.05.002.
18. Khoo HE, Azlan A, Tang ST, et al. Anthocyanidins and anthocyanins: colored pigments as food, pharmaceutical ingredients, and the potential health benefits. Food Nutr Res 2017; 61(1): 1361779, doi: 10.1080/16546628.2017.1361779.
19. Abou-Arab AA, Abu-Salem FM, Abou-Arab EA. Physico-chemical properties of natural pigments (anthocyanin) extracted from Roselle calyces (Hibiscus sabdariffa). J Am Sci 2011; 7(7): 445–446.
20. Wu H-Y, Yang K-M, Chiang P-Y. Roselle anthocyanins: antioxidant properties and stability to heat and pH. Molecules 2018; 23(6): 1357, doi: 10.3390/molecules23061357.
21. Ojeda D, Jiménez-Ferrer E, Zamilpa A, et al. Inhibition of angiotensin convertin enzyme (ACE) activity by the anthocyanins delphinidin- and cyanidin-3-O-sambubiosides from Hibiscus sabdariffa. J Ethnopharmacol 2010; 127(1): 7–10, doi: 10.1016/j.jep.2009.09.059.
22. Barrett GC, Elmore DT. Amino Acids and Peptides. Available from URL: https://books.google.com/books/about/Amino_Acids_and_Peptides.html?id=9Np_Yue4-vgC
23. Ajay M, Chai HJ, Mustafa AM, et al. Mechanisms of the anti-hypertensive effect of Hibiscus sabdariffa L. calyces. J Ethnopharmacol 2007; 109(3): 388–393, doi: 10.1016/j.jep.2006.08.005.
24. Sarr M, Ngom S, Kane MO, et al. In vitro vasorelaxation mechanisms of bioactive compounds extracted from Hibiscus sabdariffa on rat thoracic aorta. Nutr Metab 2009; 6: 45, doi: 10.1186/1743-7075-6-45.
25. Abubakar SM, Spencer JPE, Lovegrove JA. Acute impact of Hibiscus sabdariffa calyces on postprandial lipids, biomarkers of insulin resistance and inflammation in humans. Proc Nutr Soc 2016;75(OCE3). Available from URL: https://www.cambridge.org/core/services/aop-cambridge-core/content/view/E4AF2A22F6453C3BBA8E865359B09FB9/S0029665116001245a.pdf/div-class-title-acute-impact-of-span-class-italic-hibiscus-sabdariffa-span-calyces-on-postprandial-lipids-biomarkers-of-insulin-resistance-and-inflammation-in-humans-div.pdf.
26. Hopkins AL, Lamm MG, Funk JL, et al. Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies. Fitoterapia 2013; 85: 84–94, doi: 10.1016/j.fitote.2013.01.003.
27. Adamson RH. The acute lethal dose 50 (LD50) of caffeine in albino rats. Regul Toxicol Pharmacol 2016; 80: 274–276, doi: 10.1016/j.yrtph.2016.07.011.
28. Seck SM, Diop AE, Ka FE, et al. SP106 Antihypertensive efficacy of Ccombretum Micranthum and Hibiscus Ssabdariffa: a randomized controlled trial versus Ramipril. Nephrology Dialysis Transplantation 2016; 31: i120–i120, doi: 10.1093/ndt/gfw159.15.
29. Kuriyan R, Kumar DR, Rajendran R, et al. An evaluation of the hypolipidemic effect of an extract of Hibiscus Sabdariffa leaves in hyperlipidemic Indians: a double blind, placebo controlled trial. BMC Complement Altern Med 2010; 10: 27, doi: 10.1186/1472-6882-10-27.
30. McKay DL, Chen C-YO, Saltzman E, et al. Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults. J Nutr 2010; 140(2): 298–303, doi: 10.3945/jn.109.115097.
31. Ndu OO, Nworu CS, Ehiemere CO, et al. Herb-drug interaction between the extract of Hibiscus sabdariffa L. and hydrochlorothiazide in experimental animals. J Med Food 2011; 14(6): 640–644, doi: 10.1089/jmf.2010.0117.
32. Kolawole JA, Maduenyi A. Effect of zobo drink (Hibiscus sabdariffa water extract) on the pharmacokinetics of acetaminophen in human volunteers. Eur J Drug Metab Pharmacokinet 2004; 29(1): 25–29, doi: 10.1007/BF03190570.
33. Showande JS, Igbinoba SI, Kajula M, et al. In vitro modulation of cytochrome P450 isozymes and pharmacokinetics of caffeine by extracts of Hibiscus sabdariffa Linn calyx. J Basic Clin Physiol Pharmacol 2019; 30(3), doi: 10.1515/jbcpp-2018-0206.
34. Odigie IP, Ettarh RR, Adigun SA. Chronic administration of aqueous extract of Hibiscus sabdariffa attenuates hypertension and reverses cardiac hypertrophy in 2K-1C hypertensive rats. J Ethnopharmacol 2003; 86(2–3): 181–185, doi: 10.1016/s0378-8741(03)00078-3.
35. Haji Faraji M, Haji Tarkhani A. The effect of sour tea (Hibiscus sabdariffa) on essential hypertension. J Ethnopharmacol 1999; 65(3): 231–236, doi: 10.1016/s0378-8741(98)00157-3.
36. Ngamjarus C, Pattanittum P, Somboonporn C. Roselle for hypertension in adults. Cochrane Database Syst Rev 2010; 2010(1): CD007894, doi: 10.1002/14651858.CD007894.
37. Wahabi HA, Alansary LA, Al-Sabban AH, et al. The effectiveness of Hibiscus sabdariffa in the treatment of hypertension: a systematic review. Phytomedicine 2010; 17(2): 83–86, doi: 10.1016/j.phymed.2009.09.002.
38. Serban C, Sahebkar A, Ursoniu S, et al. Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: a systematic review and meta-analysis of randomized controlled trials. J Hypertens 2015; 33(6): 1119–1127, doi: 10.1097/HJH.0000000000000585.
39. Walton RJ, Whitten DL, Hawrelak JA. The efficacy of Hibiscus sabdariffa (rosella) in essential hypertension: a systematic review of clinical trials. AJHM 2016; 28(2): 48–51.
40. Nwachukwu DC, Aneke E, Nwachukwu NZ, et al. Effect of Hibiscus sabdariffaon blood pressure and electrolyte profile of mild to moderate hypertensive Nigerians: a comparative study with hydrochlorothiazide. Niger J Clin Pract 2015; 18(6): 762–770, doi: 10.4103/1119-3077.163278.
41. Boix-Castejón M, Herranz-López M, Pérez Gago A, et al. Hibiscus and lemon verbena polyphenols modulate appetite-related biomarkers in overweight subjects: a randomized controlled trial. Food Funct 2018; 9(6): 3173–3184, doi: 10.1039/c8fo00367j.
42. Herranz-López M, Olivares-Vicente M, Boix-Castejón M, et al. Differential effects of a combination of Hibiscus sabdariffa and Lippia citriodora polyphenols in overweight/obese subjects: a randomized controlled trial. Sci Rep 2019; 9(1): 1–12, doi: 10.1038/s41598-019-39159-5.
43. Nwachukwu DC, Aneke EI, Nwachukwu NZ, et al. Does consumption of an aqueous extract of Hibscus sabdariffa affect renal function in subjects with mild to moderate hypertension? J Physiol Sci 2017; 67(1): 227–234, doi: 10.1007/s12576-016-0458-z.
44. Kane SP, Phar BCPS. Sample Size Calculator [cited 28.10.2019]. Available from URL: https://clincalc.com/stats/samplesize.aspx.
45. Herrera-Arellano A, Miranda-Sánchez J, Avila-Castro P, et al. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial. Planta Med 2007; 73(1): 6–12, doi: 10.1055/s-2006-957065.
Copyright: © 2020 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.